Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASTNYSE:NOG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsNOGNorthern Oil and Gas$29.75-0.7%$28.26$19.88▼$44.31$2.94B1.51.59 million shs438,500 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%NOGNorthern Oil and Gas0.00%+2.49%+6.96%+27.44%-23.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANOGNorthern Oil and Gas4.3648 of 5 stars4.32.03.30.02.41.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/ANOGNorthern Oil and Gas 2.60Moderate Buy$39.6733.33% UpsideCurrent Analyst Ratings BreakdownLatest AST, NOG, UJO, and LBE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025NOGNorthern Oil and GasBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$29.00 ➝ $33.005/13/2025NOGNorthern Oil and GasRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Strong-Buy5/13/2025NOGNorthern Oil and GasRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$35.00 ➝ $36.005/13/2025NOGNorthern Oil and GasPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$34.00 ➝ $30.005/13/2025NOGNorthern Oil and GasMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$35.00 ➝ $33.004/14/2025NOGNorthern Oil and GasRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$40.00 ➝ $34.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/ANOGNorthern Oil and Gas$2.23B1.32$12.82 per share2.32$23.25 per share1.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/ANOGNorthern Oil and Gas$520.31M$6.424.635.38N/A26.64%23.46%10.14%7/29/2025 (Estimated)Latest AST, NOG, UJO, and LBE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025NOGNorthern Oil and Gas$0.92N/AN/AN/A$555.54 millionN/A4/29/2025Q1 2025NOGNorthern Oil and Gas$1.12$1.33+$0.21$1.39$568.87 million$602.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/ANOGNorthern Oil and Gas$1.806.05%N/A28.04%4 YearsLatest AST, NOG, UJO, and LBE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025NOGNorthern Oil and Gasquarterly$0.457.1%6/27/20256/27/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/ANOGNorthern Oil and Gas0.960.920.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/ANOGNorthern Oil and Gas98.80%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/ANOGNorthern Oil and Gas2.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableNOGNorthern Oil and Gas3098.70 million95.84 millionOptionableAST, NOG, UJO, and LBE HeadlinesRecent News About These CompaniesQ2 EPS Forecast for Northern Oil and Gas Cut by Analyst19 minutes ago | americanbankingnews.comNorthern Oil and Gas, Inc.'s (NYSE:NOG) Stock Is Going Strong: Is the Market Following Fundamentals?July 5 at 11:36 AM | finance.yahoo.comZacks Research Issues Negative Outlook for NOG EarningsJuly 5 at 2:10 AM | americanbankingnews.comResearch Analysts Offer Predictions for NOG Q2 EarningsJuly 4 at 7:03 AM | marketbeat.comNorthern Oil and Gas, Inc. (NYSE:NOG) Receives $39.67 Consensus PT from AnalystsJuly 4 at 2:27 AM | americanbankingnews.comZacks Research Issues Negative Forecast for NOG EarningsJuly 3 at 7:09 AM | marketbeat.comPeregrine Capital Management LLC Purchases 21,634 Shares of Northern Oil and Gas, Inc. (NYSE:NOG)July 1, 2025 | marketbeat.comNorthern Oil and Gas, Inc. (NYSE:NOG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJuly 1, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Grows Position in Northern Oil and Gas, Inc. (NYSE:NOG)June 30, 2025 | marketbeat.comCopeland Capital Management LLC Sells 71,995 Shares of Northern Oil and Gas, Inc. (NYSE:NOG)June 28, 2025 | marketbeat.comNOG Northern Oil and Gas, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comNorthern Oil And Gas: A Fair Income Play With Potential Price RecoveryJune 25, 2025 | seekingalpha.comState of Alaska Department of Revenue Increases Stake in Northern Oil and Gas, Inc. (NYSE:NOG)June 22, 2025 | marketbeat.comNorthern Oil and Gas Completes $200M Convertible Notes PlacementJune 18, 2025 | tipranks.comNOG Closes Upsized Reopening of its 3.625% Convertible Unsecured Senior Notes Due 2029June 17, 2025 | businesswire.comNorthern Oil and Gas, Inc. (NYSE:NOG) Shares Bought by GAMMA Investing LLCJune 15, 2025 | marketbeat.comIf EPS Growth Is Important To You, Northern Oil and Gas (NYSE:NOG) Presents An OpportunityJune 14, 2025 | finance.yahoo.comNorthern Oil and Gas (NYSE:NOG) Shares Gap Up - Time to Buy?June 13, 2025 | marketbeat.comNorthern Oil and Gas prices $175M convertible senior notesJune 13, 2025 | msn.comNOG Prices Upsized $175.0 Million Reopening of 3.625% Convertible Senior Notes Due 2029June 12, 2025 | finance.yahoo.comNOG Announces Proposed Reopening of 3.625% Convertible Senior Notes Due 2029June 12, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeAST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!By Thomas Hughes | June 16, 2025View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500By Sam Quirke | June 30, 2025View Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500Rocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseAST, NOG, UJO, and LBE Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.Northern Oil and Gas NYSE:NOG$29.75 -0.20 (-0.67%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$29.48 -0.27 (-0.89%) As of 07/3/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Northern Oil and Gas, Inc., an independent energy company, engages in the acquisition, exploration, exploitation, development, and production of crude oil and natural gas properties in the United States. It primarily holds interests in the Williston Basin, the Appalachian Basin, and the Permian Basin in the United States. The company is based in Minnetonka, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
